| Artificial Limb Specialist | |
| 7600 N. 15th Street, Suite 105, Phoenix, Arizona 85020 | |
| (602) 745-2080 |
| Name | Artificial Limb Specialist |
|---|---|
| Organization Name | Artificial Limb Specialists Llc |
| Location | 7600 N. 15th Street, Suite 105, Phoenix, Arizona 85020 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (602) 745-2080 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).
Ilana Witten didn't set out to study spatial learning. She thought she was investigating how mice socialize-but she discovered that in mouse brains, the social and the spatial are inextricably linked.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.
The proposed rule also would provide payment for care that helps patients make the transition back into the community following a discharge from a hospital or nursing facility.
› Verified 3 days ago
| NPI Number | 1578541579 |
| Organization Name | ARTIFICIAL LIMB SPECIALISTS LLC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 7600 N 15th St, Suite 105, Phoenix, AZ 85020 |
| Phone Number | 602-745-2080 |
News Archive
Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).
Ilana Witten didn't set out to study spatial learning. She thought she was investigating how mice socialize-but she discovered that in mouse brains, the social and the spatial are inextricably linked.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.
The proposed rule also would provide payment for care that helps patients make the transition back into the community following a discharge from a hospital or nursing facility.
› Verified 3 days ago
| NPI Number | 1760180731 |
| Organization Name | OTTO BOCK PATIENT CARE, LLC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 7600 N 15th St Ste 105, Phoenix, AZ 85020 |
| Phone Number | 602-745-2080 |
News Archive
Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).
Ilana Witten didn't set out to study spatial learning. She thought she was investigating how mice socialize-but she discovered that in mouse brains, the social and the spatial are inextricably linked.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.
The proposed rule also would provide payment for care that helps patients make the transition back into the community following a discharge from a hospital or nursing facility.
› Verified 3 days ago
News Archive
Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).
Ilana Witten didn't set out to study spatial learning. She thought she was investigating how mice socialize-but she discovered that in mouse brains, the social and the spatial are inextricably linked.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.
The proposed rule also would provide payment for care that helps patients make the transition back into the community following a discharge from a hospital or nursing facility.
› Verified 3 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |